Lv4
460 积分 2022-03-13 加入
Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study
16小时前
待确认
A real-world pharmacovigilance analysis of the FDA adverse event reporting system events for polatuzumab vedotin
1个月前
已完结
Outcomes of haploidentical haematopoietic stem cell transplantation for adolescent and young adults with acute myeloid leukaemia
3个月前
已完结
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
3个月前
已关闭
Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation—A systematic review and meta-analysis
3个月前
已完结
皖公网安备34019202002308
